Anhui Huaheng Financials
| 688639 Stock | 32.61 0.34 1.03% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 290.9 M | 514.8 M |
|
|
Anhui | Select Account or Indicator |
Understanding current and past Anhui Huaheng Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Anhui Huaheng's financial statements are interrelated, with each one affecting the others. For example, an increase in Anhui Huaheng's assets may result in an increase in income on the income statement.
Please note, the presentation of Anhui Huaheng's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Anhui Huaheng's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Anhui Huaheng's management manipulating its earnings.
Anhui Huaheng Stock Summary
Anhui Huaheng competes with Industrial, Agricultural Bank, China Construction, Bank of China, and Postal Savings. Anhui Huaheng is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE1000052M6 |
| Business Address | No32 Fengjin Road, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.huahengbio.com |
| Phone | 86 551 6568 9170 |
You should never invest in Anhui Huaheng without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Anhui Stock, because this is throwing your money away. Analyzing the key information contained in Anhui Huaheng's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Anhui Huaheng Key Financial Ratios
Anhui Huaheng's financial ratios allow both analysts and investors to convert raw data from Anhui Huaheng's financial statements into concise, actionable information that can be used to evaluate the performance of Anhui Huaheng over time and compare it to other companies across industries.| Revenue | 1.94 B | ||||
| Gross Profit | 343.67 M | ||||
| EBITDA | 482.93 M | ||||
| Net Income | 449.06 M | ||||
| Total Asset | 3.97 B |
Anhui Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Anhui Huaheng's current stock value. Our valuation model uses many indicators to compare Anhui Huaheng value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Anhui Huaheng competition to find correlations between indicators driving Anhui Huaheng's intrinsic value. More Info.Anhui Huaheng Biotechnology is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.33 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Anhui Huaheng Biotechnology is roughly 3.03 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Anhui Huaheng by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Anhui Huaheng's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Anhui Huaheng Biotec Systematic Risk
Anhui Huaheng's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Anhui Huaheng volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Anhui Huaheng Biotec correlated with the market. If Beta is less than 0 Anhui Huaheng generally moves in the opposite direction as compared to the market. If Anhui Huaheng Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Anhui Huaheng Biotec is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Anhui Huaheng is generally in the same direction as the market. If Beta > 1 Anhui Huaheng moves generally in the same direction as, but more than the movement of the benchmark.
Anhui Huaheng Biotechnology Total Assets Over Time
Anhui Huaheng Thematic Clasifications
Anhui Huaheng Biotechnology is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
| Biotech | View |
Anhui Huaheng December 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Anhui Huaheng help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Anhui Huaheng Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Anhui Huaheng Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing Anhui Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Anhui Huaheng's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.24 | |||
| Information Ratio | 0.0619 | |||
| Maximum Drawdown | 33.71 | |||
| Value At Risk | (5.43) | |||
| Potential Upside | 9.68 |
Complementary Tools for Anhui Stock analysis
When running Anhui Huaheng's price analysis, check to measure Anhui Huaheng's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anhui Huaheng is operating at the current time. Most of Anhui Huaheng's value examination focuses on studying past and present price action to predict the probability of Anhui Huaheng's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anhui Huaheng's price. Additionally, you may evaluate how the addition of Anhui Huaheng to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |